Should I buy Bath & Body Works, Inc. (BBWI) stock or is it too late?
⭐ The most reliable of them, either direction: Jefferies — 57% of its targets hit on this sector (145 calls tested). It aims for $23 (+23 %), call made on July 29, 2026, maturing on July 29, 2027 (30 d ago).
Firm-by-firm track record on Bath & Body Works, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Baird | 12 % | -16.4 % | 8 | $19 +2% |
| Telsey Advisory Group | 26 % | -17.6 % | 38 | $22 +18% |
| Goldman Sachs | 0 % | -18.7 % | 8 | $19 +2% |
| Morgan Stanley | 20 % | -19.2 % | 10 | $18 -3% |
| Wells Fargo | 12 % | -24.9 % | 8 | $26 +39% |
| Citigroup | 12 % | -26.5 % | 8 | $25 +34% |
| JP Morgan | 0 % | -31.1 % | 7 | $24 +29% |
| Raymond James | 60 % | +0.3 % | 10 | — |
✅ Reasons to believe
- Median price target $23, i.e. +23% from the current price ($19).
- The most reliable firm on BBWI, Barclays (100% hit rate, 3 scored calls), targets $23 (call made on May 28, 2026, maturing on May 28, 2027) (+23%) in its most recent call, and $32 (call made on August 29, 2025, maturing on August 29, 2026) (+72%) in the one coming due soonest.
- Pays a dividend (3.6% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 9 ratings, 5 are neutral and 1 is a sell.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on BBWI
Median target $23 (+23%) · 9 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Bath & Body Works, Inc. now?
We won't decide for you. The facts: 33% of analysts rate it a buy, median target $23 (+23%), and Barclays (most reliable on BBWI, 100%) targets $23. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Bath & Body Works, Inc.?
Not according to analysts: the median target ($23) is still +23% above the current price ($19) (most reliable on BBWI: Barclays, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Bath & Body Works, Inc. still worth investing in?
It depends on the gap between the price ($19) and its estimated value: analysts target $23 on median (+23%), with 33% buys (most reliable on BBWI: Barclays, 100%). Cross-check with their real reliability on BBWI and the cautions above. Information, not advice.
What's the main risk in buying BBWI?
The consensus is not unanimous: of 9 ratings, 5 are neutral and 1 is a sell.
→ Go deeper: the full Bath & Body Works, Inc. profile (consensus, analyst reliability, price target, performance).